From Assay to Action – Making MRD a Practical Tool for Treatment Decisions in Hematology

• Bridging assay development and translational research to define clinically meaningful MRD cut-offs and endpoints
• Designing MRD-guided clinical trials to inform treatment decisions, including escalation, consolidation & de-escalation strategies
• Addressing turnaround time, cost and implementation challenges to ensure MRD assays can move from trials into routine practice

Speakers:

Yanwen Jiang

Scientist

Genentech